Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants

Carl T. D'Angio, Roy J. Heyne, T. Michael O'Shea, Robert L. Schelonka, Seetha Shankaran, Shahnaz Duara, Ronald N. Goldberg, Barbara J. Stoll, Krisa P. Van Meurs, Betty R. Vohr, Abhik Das, Lei Li, Robert L. Burton, Betty Hastings, Dale L. Phelps, Pablo J. Sanchez, Waldemar A. Carlo, David K. Stevenson, Rosemary D. Higgins

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Background: The heptavalent pneumococcal CRM197 conjugate vaccine (PCV-7) has been incompletely studied in very-low-birth-weight (≤1500 g) infants. Objective: To assess PCV-7 immunogenicity in very-low-birth-weight, premature infants. We hypothesized that the frequency of postvaccine antibody concentrations 0.15 μg/mL would vary directly with birth weight. Methods: This was a multicenter observational study. Infants 401 to 1500 g birth weight and <32 0/7 weeks gestation, stratified by birth weight, were enrolled from 9 National Institute of Child Health and Human Development Neonatal Research Network centers. Infants received PCV-7 at 2, 4, and 6 months after birth and had blood drawn 4 to 6 weeks following the third dose. Antibodies against the 7 vaccine serotypes were measured by enzyme-linked immunosorbent assay. Results: Of 369 enrolled infants, 244 completed their primary vaccine series by 8 months and had serum obtained. Subjects were 27.8 ± 2.2 (mean ± standard deviation) weeks gestation and 1008 ± 282 g birth weight. Twenty-six percent had bronchopulmonary dysplasia and 16% had received postnatal glucocorticoids. Infants 1001 to 1500 g birth weight were more likely than those 401 to 1000 g to achieve antibody concentrations 0.15 μg/mL against the least 2 immunogenic serotypes (6B: 96% vs. 85%, P = 0.003 and 23F: 97% vs. 88%, P = 0.009). In multiple logistic regression analysis, lower birth weight, postnatal glucocorticoid use, lower weight at blood draw, and Caucasian race were each independently associated with antibody concentrations <0.35 μg/mL against serotypes 6B and/or 23F. Conclusions: When compared with larger premature infants, infants weighing ≤1000 g at birth have similar antibody responses to most, but not all, PCV-7 vaccine serotypes.

Original languageEnglish (US)
Pages (from-to)600-606
Number of pages7
JournalPediatric Infectious Disease Journal
Volume29
Issue number7
DOIs
StatePublished - Jul 2010

Keywords

  • immunization
  • pneumococcal vaccines
  • premature infant
  • vaccines
  • very low birth weight infant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants'. Together they form a unique fingerprint.

  • Cite this

    D'Angio, C. T., Heyne, R. J., O'Shea, T. M., Schelonka, R. L., Shankaran, S., Duara, S., Goldberg, R. N., Stoll, B. J., Van Meurs, K. P., Vohr, B. R., Das, A., Li, L., Burton, R. L., Hastings, B., Phelps, D. L., Sanchez, P. J., Carlo, W. A., Stevenson, D. K., & Higgins, R. D. (2010). Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants. Pediatric Infectious Disease Journal, 29(7), 600-606. https://doi.org/10.1097/INF.0b013e3181d264a6